In addition to checkpoint inhibitors in T cells, immunotherapy now includes inhibition of macrophage’s “Do not eat me” signal on cancer cells, mainly through the interaction of CD47 on the tumor cells with signal-regulatory protein α (SIRPα) on the macrophages. The gene discussed is CD47; the disease is neoplasm.